首站-论文投稿智能助手
典型文献
精神科住院老年患者潜在不适当用药情况及影响因素分析
文献摘要:
目的:分析精神科住院老年患者潜在不适当用药情况及其影响因素.方法:选取2019年6月—2020年7月我院精神科收治500例住院患者进行回顾性分析,根据《中国老年人潜在不适当用药判断标准(2017年版)》评价老年住院患者(Potentially inappropriate medication,PIM)情况,并将患者分为PIM组(471例)和对照组(29例),分析发生PIM的危险因素.结果:500例精神科住院患者中,发生PIM有470例(94.00%),其中涉及药物频率和占PIM总发生比例较高的前5种药物依次为劳拉西泮、奥氮平、艾司唑仑、喹硫平和氯硝西泮.单因素分析显示,PIM组和对照组年龄、住院天数、罹患疾病数、联合用药数比较,差异有统计学意义(P<0.05).多因素Logistic回归分析显示,年龄、罹患疾病数、联合用药数是精神科住院老年患者PIM发生的独立危险因素.结论:精神科住院老年患者PIM发生率较高,且其危险因素包括患者年龄、罹患疾病数、联合用药数.应在早期对其影响因素进行有效干预,优化患者临床用药,减少PIM的发生,促进精神科住院老年患者合理用药.
文献关键词:
精神科;老年患者;潜在不适当用药;影响因素
作者姓名:
蔡荣;魏新敏
作者机构:
广东省广州市番禺区第三人民医院精神科,广东广州 511483
引用格式:
[1]蔡荣;魏新敏-.精神科住院老年患者潜在不适当用药情况及影响因素分析)[J].中国药物滥用防治杂志,2022(08):1026-1030
A类:
B类:
精神科住院,住院老年患者,用药情况,我院,中国老年人潜在不适当用药判断标准,老年住院患者,Potentially,inappropriate,medication,PIM,劳拉西泮,奥氮平,艾司唑仑,喹硫平,氯硝西泮,住院天数,罹患,联合用药,患者年龄,临床用药,合理用药
AB值:
0.192015
相似文献
神经精神药理学治疗药物监测共识指南:2017版
C.Hiemke;N.Bergemann;H.W.Clement;A.Conca;J.Deckert;K.Domschke;G.Eckermann;K.Egberts;M.Gerlach;C.Greiner;G.Gründer;E.Haen;U.Havemann-Reinecke;G.Hefner;R.Helmer;G.Janssen;E-.Jaquenoud;G.Laux;T.Messer;R.M?ssner;M.J.Müller;M.Paulzen;B.Pfuhlmann;P.Riederer;A.Saria;B.Schoppek;G.Schoretsanitis;M.Schwarz;M.Silva Gracia;B.Stegmann;W.Steimer;J.C.Stingl;M.Uhr;S.Ulrich;S.Unterecker;R.Waschgler;G.Zernig;G.Zurek;P.Baumann;李文标;果伟;贺静;鲍爽;路钊;牛梦溪;阮灿军;臧彦楠;王勇;张玲;刘辰庚;李洁-Department of Psychiatry and Psychotherapy,University Medical Center of Mainz,Mainz,Germany;Institute of Clinical Chemistry and Laboratory Medicine,University Medical Center of Mainz,Mainz,Germany;Kitzberg Hospitals,Center for Psychosomatic Medicine and Psychotherapy,Bad Mergentheim,Germany;Department of Child and Adolescent Psychiatry,University of Freiburg,Freiburg,Germany;Servizio Psichiatrico del Comprensorio Sanitario di Bolzano,Bolzano,Italy;Department of Psychiatry,Psychotherapy and Psychosomatics,University Hospital of Würzburg,Germany;Department of Psychiatry and Psychotherapy, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg,Freiburg,Germany;Psychiatric Hospital,Kaufbeuren,Germany;Department of Child and Adolescent Psychiatry,Psychosomatics and Psychotherapy,Center of Mental Health,University Hospi-tal of Würzburg,Germany;Federal Institute for Drugs and Medical Devices (BfArM),Bonn,Germany;Department of Psychiatry,Psychotherapy and Psychosomatics,RWTH Aachen University,Aachen,and JARA–Translational Brain Medicine,Aachen,Germany;Clinical Pharmacology,Department of Psychiatry and Psychotherapy and Department of Pharmacology and Toxicology,Uni-versity of Regensburg,Regensburg,Germany;Department of Psychiatry and Psychosomatics,University of G?ttingen,G?ttingen,Germany;Psychiatric Hospital,Vitos Klinik,Eichberg,Eltville,Germany;Center of Epilepsy,Bielefeld,Germany;Medical Laboratory Stein,Limbach Group,M?nchengladbach,Germany;Psychiatric Hospital,K?nigsfelden,Brugg,Aargau,Switzerland;Institute of Psychological Medicine,Haag in Oberbayern,Germany;Danuviuskliniken,Psychiatric Hospital,Pfaffenhofen,Germany;Department of Psychiatry and Psychotherapy,University of Tübingen,Tübingen,Germany;Psychiatric Hospitals Oberberggruppe,Berlin,Germany;Psychiatric Hospital Weisser Hirsch,Dresden,Germany;Experimental Psychiatry Unit,Department of Psychiatry1,Medical University of Innsbruck,Innsbruck,Austria;kbo-Isar-Amper Klinikum München-Ost,Psychiatric Hospital,Munich-Haar,Germany;Department of Psychiatry,University of Bern,Bern,Switzerland;Department of Laboratory Medicine,Ludwig Maximilian University,Munich,Germany;Institute of Clinical Chemistry and Pathobiochemistry,Technical University Munich,Munich,Germany;Max Planck Institute of Psychiatry,Munich,Germany;Aristo Pharma GmbH,Berlin,Germany;Psychiatric Hospital,Feldkirch,Austria;Private Practice for Psychotherapy and Court-Certified Witness,Hall in Tirol,Austria;Medical Laboratory Bremen,Bremen,Germany;Department of Psychiatry,University of Lausanne,Prilly-Lausanne,Switzerland;中国 北京 首都医科大学附属北京安定医院,国家精神心理疾病临床医学研究中心,精神疾病诊断与治疗北京重点实验室;中国 天津 天津市安定医院
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。